|
SEER Required
Site-Specific Factors (SSF) for Collaborative Staging Version 2 (CSv2). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Color Legend: |
Grey |
Obsolete - not collected |
Blue |
Already collected |
|
Red |
Needed for staging |
|
Green |
Additional clinically
significant |
|
|
White |
Not required at this time |
|
|
SSF4
for prostate is required thru 2009 but is not required for 2010+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schema
Name |
SSF 1 |
SSF 2 |
SSF 3 |
SSF 4 |
SSF 5 |
SSF 6 |
SSF 7 |
SSF 8 |
SSF 9 |
SSF 10 |
SSF 11 |
SSF 12 |
SSF 13 |
SSF 14 |
SSF 15 |
SSF 16 |
SSF 17 |
SSF 18 |
SSF 19 |
SSF 20 |
SSF 21 |
SSF 22 |
SSF 23 |
SSF 24 |
SSF 25 |
| AdnexaUterineOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AdrenalGland |
OBSOLETE (WHO Grade Classification) |
Tumor Gland Weight |
Vascular Invasion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AmpullaVater |
CA 19-9 Lab Value |
Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Lab Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anus |
HPV Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Appendix |
Carcinoembryonic Antigen (CEA) |
Clinical Assessment of Regional Lymph Nodes |
Carcinoembryonic Antigen (CEA) Lab Value |
Tumor Deposits |
|
|
Micro-satellite Instability |
|
|
18q Loss of Heterozygosity (LOH) |
Histopathological Grading |
CA 19-9 Lab Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
| BileDuctsDistal |
|
|
|
|
|
|
|
|
|
|
|
Pre-Operative CA 19-9 Lab Value |
Pre-Operative Carcinoembryonic Antigen (CEA) |
Pre-Operative Carcinoembryonic Antigen (CEA) Lab Value |
|
|
|
|
|
|
|
|
|
|
Schema Discriminator:
Subsite of Extrahepatic Bile Ducts |
| BileDuctsIntraHepat |
Alpha Fetoprotein (AFP) Interpretation |
Fibrosis Score |
Alpha Fetoprotein (AFP) Lab Value |
|
|
|
|
|
|
Tumor Growth Pattern |
Primary Sclerosing Cholangitis |
Pre-Operative CA 19-9 Lab Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
| BileDuctsPerihilar |
|
|
|
|
|
|
|
|
|
Tumor Growth Pattern |
Primary Sclerosing Cholangitis |
Pre-Operative CA 19-9 Lab Value |
Pre-Operative Carcinoembryonic Antigen (CEA) |
Pre-Operative Carcinoembryonic Antigen (CEA) Lab Value |
|
|
|
|
|
|
|
|
|
|
Schema Discriminator:
Subsite of Extrahepatic Bile Ducts |
| BiliaryOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bladder |
WHO/ISUP Grade |
Size of Metastasis in Lymph Nodes |
Extranodal Extension of Regional Lymph Nodes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bone |
CS Tumor Size - Second Largest Dimension |
CS Tumor Size - Third Largest Dimension |
Percent necrosis post neoadjuvant chemotherapy |
Resected pulmonary metastasis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Brain |
WHO Grade Classification |
Proliferative Fraction- Ki-67/MIB-1 |
Function neurological status- The Karnofsky Performance
Score/Scale |
MGMT - Methylation of MGMT |
Gene Deletions 1p |
Chromosome 19q: Loss of Heterozygosity (LOH) |
Surgical Resection |
Focus of Primary Tumor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Breast |
Estrogen Receptor Assay (ERA) |
Progesterone Receptor Assay (PRA) |
Number of Positive Ipsilateral Level I-II Axillary Lymph Nodes |
Immunohistochemistry (IHC) of Regional Lymph Nodes |
Molecular Studies of Regional Lymph Nodes |
Size of Tumor--Invasive Component |
Nottingham or Bloom-Richardson (BR) Score/Grade |
HER2: IHC Test Lab Value |
HER2: IHC Test Interpretation |
HER2: Fish Test Lab Value |
HER2: FISH Test Interpretation |
HER2: CISH Test Lab Value |
HER2: CISH Test Interpretation |
HER2: Result of other or unknown test |
HER2: Summary Result of Testing |
Combinations of ER, PR, and HER2 |
Circulating Tumor Cells (CTC) and method of detection |
Disseminated Tumor Cells (DTC) and method of detection |
Assessment of Ipsilateral Axillary Lymph Nodes |
Assessment of Positive Distant Metastases |
Response to Neoadjuvant Therapy |
Multigene Signature Method |
Code the result/score of the multigene signature |
Paget Disease |
|
| BuccalMucosa |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CarcinoidAppendix |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
Clinical Assessment of Regional Lymph Nodes |
|
|
|
|
|
|
|
|
|
|
Serum Chromogranin A (CgA) Lab Value |
|
|
|
|
|
|
|
|
|
|
|
|
| Cervix |
FIGO Stage |
Pelvic Nodal Status |
Assessment Method of Pelvic Nodal Status |
Para-Aortic Nodal Status |
Assessment Method of Para-aortic Nodal Status |
Mediastinal Node Status |
Assessment Method of Mediastinal Node Status |
Scalene Node Status |
Assessment Method of Scalene Node Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CNSOther |
WHO Grade Classification |
Proliferative Fraction- Ki-67/MIB-1 |
Function neurological status- The Karnofsky Performance
Score/Scale |
MGMT - Methylation of MGMT |
Gene Deletions 1p |
Chromosome 19q: Loss of Heterozygosity (LOH) |
Surgical Resection |
Focus of Primary Tumor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Colon |
Carcinoembryonic Antigen (CEA) |
Clinical Assessment of Regional Lymph Nodes |
Carcinoembryonic Antigen (CEA) Lab Value |
Tumor Deposits |
Tumor Regression Grade |
Circumferential Resection Margin (CRM) |
Micro-satellite Instability |
Perineural Invasion |
KRAS |
18q Loss of Heterozygosity (LOH) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conjunctiva |
Tumor Size |
Ki-67 Labeling Index Lab Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CorpusAdenosarcoma |
FIGO Stage |
Peritoneal Cytology |
Number of Positive Pelvic Nodes |
Number of Examined Pelvic Nodes |
Number of Positive Para-Aortic Nodes |
Number of Examined Para-Aortic Nodes |
Percentage of Non-Endometrioid Cell Type in Mixed Histology
Tumors |
Omentectomy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CorpusCarcinoma |
FIGO Stage |
Peritoneal Cytology |
Number of Positive Pelvic Nodes |
Number of Examined Pelvic Nodes |
Number of Positive Para-Aortic Nodes |
Number of Examined Para-Aortic Nodes |
Percentage of Non-Endometrioid Cell Type in Mixed Histology
Tumors |
Omentectomy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CorpusSarcoma |
FIGO Stage |
Peritoneal Cytology |
Number of Positive Pelvic Nodes |
Number of Examined Pelvic Nodes |
Number of Positive Para-Aortic Nodes |
Number of Examined Para-Aortic Nodes |
Percentage of Non-Endometrioid Cell Type in Mixed Histology
Tumors |
Omentectomy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CysticDuct |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator:
Subsite of Extrahepatic Bile Ducts |
| DigestiveOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EndocrineOther |
OBSOLETE (WHO Grade Classification) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EpiglottisAnterior |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Esophagus |
Clinical Assessment of Regional Lymph Nodes |
Specific Location of Tumor |
Number of Regional Lymph Nodes with Extracapsular tumor |
Distance to proximal edge of tumor from incisors |
Distance to distal edge of tumor from incisors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EsophagusGEJunction |
Clinical Assessment of Regional Lymph Nodes |
|
Number of Regional Lymph Nodes with Extracapsular tumor |
Distance to proximal edge of tumor from incisors |
Distance to distal edge of tumor from incisors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involvement of Cardia and Distance from Esophagogastric Junction
(EGJ) |
| EyeOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FallopianTube |
Figo Stage |
Biopsy of Metastatic Site |
Primary Tumor Location |
Number of Positive Pelvic Nodes |
Number of Examined Pelvic Nodes |
Number of Positive Para-Aortic Nodes |
Number of Examined Para-Aortic Nodes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FloorMouth |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gallbladder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Extent of Liver Resection |
Primary Tumor Location Within Gallbladder |
|
|
|
|
|
|
|
|
|
| GenitalFemaleOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GenitalMaleOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GISTAppendix |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
OBSOLETE (Clinical Assessment of Regional Lymph Nodes) |
|
|
|
|
|
|
|
|
Mitotic Count |
KIT Gene Immunohistochemistry (IHC) |
KIT Gene Mutations |
PDGFRA Gene Mutation |
Tumor Multiplicity |
|
|
|
|
|
|
|
|
|
|
| GISTColon |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
OBSOLETE (Clinical Assessment of Regional Lymph Nodes) |
|
|
|
|
|
|
|
|
Mitotic Count |
KIT Gene Immunohistochemistry (IHC) |
KIT Gene Mutations |
PDGFRA Gene Mutation |
Tumor Multiplicity |
|
|
|
|
|
|
|
|
|
|
| GISTEsophagus |
|
|
|
|
|
Mitotic Count |
KIT Immunohistochemistry (IHC) |
KIT Gene Mutation |
PDGFRA Gene Mutation |
Tumor Multiplicity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GISTPeritoneum |
|
|
|
|
Mitotic Count |
KIT Immunohistochemistry (IHC) |
KIT Gene Mutation |
PDGFRA Gene Mutation |
Tumor Multiplicity |
Location of Primary Tumor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GISTRectum |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
OBSOLETE (Clinical Assessment of Regional Lymph Nodes) |
|
|
|
|
|
|
|
|
Mitotic Count |
KIT Gene Immunohistochemistry (IHC) |
KIT Gene Mutations |
PDGFRA Gene Mutation |
Tumor Multiplicity |
|
|
|
|
|
|
|
|
|
|
| GISTSmallIntestine |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
|
|
|
|
Mitotic Count |
KIT Immunohistochemistry (IHC) |
KIT Gene Mutation |
PDGFRA Gene Mutation |
Tumor Multiplicity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GISTStomach |
OBSOLETE (Clinical Assessment of Regional Lymph Nodes) |
|
|
|
|
Mitotic Count |
KIT Immunohistochemistry (IHC) |
KIT Gene Mutation |
PDGFRA Gene Mutation |
Tumor Multiplicity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GumLower |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GumOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GumUpper |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HeartMediastinum |
Grade for Sarcomas |
Neurovascular Invasion |
Bone invasion |
Pathologic P1: Source of pathologic metastatic specimen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HemeRetic |
JAK-2 (also known as Janus Kinase 2 and JAK 2 Exon 12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hypopharynx |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IllDefinedOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IntracranialGland |
WHO Grade Classification |
Proliferative Fraction- Ki-67/MIB-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KaposiSarcoma |
Associated with HIV/AIDS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KidneyParenchyma |
Invasion Beyond Capsule |
Vein Involvement |
Ipsilateral Adrenal Gland Involvement |
Sarcomatoid Features |
Histologic Tumor Necrosis |
Fuhrman Nuclear Grade |
Size of Metastasis in Lymph Nodes |
Extranodal Extension of Regional Lymph Nodes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KidneyRenalPelvis |
WHO/ISUP Grade |
Depth of Renal Parenchymal Invasion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LacrimalGland |
Ki-67 Labeling Index Lab Value |
Nuclear NM23 Staining |
Clinical Evaluation of Lymph Nodes |
Perineural Invasion |
Carcinoma ex Pleomorphic Adenoma, Invasion beyond capsule |
Adenoid cystic carcinoma - Presence of basaloid pattern |
Mucoepidermoid Carcinoma - Grade |
Orbital Bone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator: Lacrimal Gland/Lacrimal Sac |
| LacrimalSac |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator: Lacrimal Gland/Lacrimal Sac |
| LarynxGlottic |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LarynxOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LarynxSubglottic |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LarynxSupraglottic |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LipLower |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LipOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LipUpper |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Liver |
Alpha Fetoprotein (AFP) Interpretation |
Fibrosis Score |
Alpha Fetoprotein (AFP) Lab Value |
Creatinine Value |
Creatinine Unit of Measure |
Total Bilirubin Value |
Total Bilirubin Unit of Measure |
International Normalized Ratio for Prothrombin Time (INR) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lung |
Separate Tumor Nodules/Ipsilateral Lung |
Visceral Pleural Invasion (VPI)/Elastic Layer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lymphoma |
Associated with HIV/AIDS |
Systemic Symptoms at Diagnosis |
International Prognostic Index (IPI) |
Follicular Lymphoma Prognostic Index (FLIPI) |
International Prognostic Score (IPS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LymphomaOcularAdnexa |
Associated with HIV/AIDS |
Systemic Symptoms at Diagnosis |
International Prognostic Index (IPI) |
Follicular Lymphoma Prognostic Index (FLIPI) |
Ki-67 Labeling Index Lab Value |
LDH Interpretation |
Rheumatoid Arthritis |
Sjogren Syndrome |
Other Connective Tissue Disease |
Sicca Syndrome |
Other Viral Infection |
Bacterial Infection |
Other infection |
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaBuccalMucosa |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaChoroid |
OBSOLETE Measured Thickness (Depth) |
Measured Basal Diameter |
Measured Thickness (Depth) |
Size of Largest Metastasis |
Chromosome 3 Status |
Chromosome 6p Status |
Chromosome 8q Status |
Gene Expression Profile |
Mitotic Count |
Mean Diameter Nucleoli (MLN) |
Extravascular Matrix Patterns, Loops |
Extravascular Matrix Patterns, Networks |
Microvascular density (MVD) |
PET Standardized Uptake Values (SUV) |
|
|
|
|
|
|
|
|
|
|
|
| MelanomaCiliaryBody |
OBSOLETE Measured Thickness (Depth) |
Measured Basal Diameter |
Measured Thickness (Depth) |
Size of Largest Metastasis |
Chromosome 3 Status |
Chromosome 6p Status |
Chromosome 8q Status |
Gene Expression Profile |
Mitotic Count |
Mean Diameter Nucleoli (MLN) |
Extravascular Matrix Patterns, Loops |
Extravascular Matrix Patterns, Networks |
Microvascular density (MVD) |
PET Standardized Uptake Values (SUV) |
|
|
|
|
|
|
|
|
|
|
Schema Discriminator: Melanoma Ciliary Body/Melanoma Iris |
| MelanomaConjunctiva |
Measured Thickness (Depth) |
Quadrants |
Grade - Melanoma Origin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaEpiglottisAnterior |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaEyeOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaFloorMouth |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaGumLower |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaGumOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaGumUpper |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaHypopharynx |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaIris |
OBSOLETE Measured Thickness (Depth) |
Measured Basal Diameter |
Measured Thickness (Depth) |
Size of Largest Metastasis |
Chromosome 3 Status |
Chromosome 6p Status |
Chromosome 8q Status |
Gene Expression Profile |
Mitotic Count |
Mean Diameter Nucleoli (MLN) |
Extravascular Matrix Patterns, Loops |
Extravascular Matrix Patterns, Networks |
Microvascular density (MVD) |
PET Standardized Uptake Values (SUV) |
|
|
|
|
|
|
|
|
|
|
Schema Discriminator: Melanoma Ciliary Body/Melanoma Iris |
| MelanomaLarynxGlottic |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaLarynxOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaLarynxSubglottic |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaLarynxSupraglottic |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaLipLower |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaLipOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaLipUpper |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaMouthOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaNasalCavity |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaNasopharynx |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaOropharynx |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaPalateHard |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaPalateSoft |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaPharynxOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaSinusEthmoid |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaSinusMaxillary |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaSinusOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaSkin |
Measured Thickness (Depth), Breslow's Measurement |
Ulceration |
Clinical Status of Lymph Node Mets |
LDH |
LDH VALUE |
LDH Upper Limits of Normal |
Primary Tumor Mitotic Count/Rate |
Primary Tumor Regression |
Vertical Growth Phase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaTongueAnterior |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MelanomaTongueBase |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MerkelCellPenis |
Measured Thickness (Depth) |
|
Clinical Status of Lymph Node Mets |
|
|
|
|
|
|
|
|
|
|
|
|
Size of Metastasis in Lymph Nodes |
Extracapsular Extension of Regional Lymph Nodes |
Isolated Tumor Cells (ITCs) in Regional Lymph Node(s) |
Tumor Base Transection Status |
Tumor Infiltrating Lymphocytes (TIL) |
Growth Pattern of Primary Tumor |
Profound Immune Suppression |
|
|
|
| MerkelCellScrotum |
Measured Thickness (Depth) |
|
Clinical Status of Lymph Node Mets |
|
|
|
|
|
|
|
|
|
|
|
|
Size of Metastasis in Lymph Nodes |
Extracapsular Extension of Regional Lymph Nodes |
Isolated Tumor Cells (ITCs) in Regional Lymph Node(s) |
Tumor Base Transection Status |
Tumor Infiltrating Lymphocytes (TIL) |
Growth Pattern of Primary Tumor |
Profound Immune Suppression |
|
|
|
| MerkelCellSkin |
Measured Thickness (Depth) |
|
Clinical Status of Lymph Node Mets |
|
|
|
|
|
|
|
|
|
|
|
|
Size of Metastasis in Lymph Nodes |
Extracapsular Extension of Regional Lymph Nodes |
Isolated Tumor Cells (ITCs) in Regional Lymph Node(s) |
Tumor Base Transection Status |
Tumor Infiltrating Lymphocytes (TIL) |
Growth Pattern of Primary Tumor |
Profound Immune Suppression |
|
|
|
| MerkelCellVulva |
Measured Thickness (Depth) |
|
Clinical Status of Lymph Node Mets |
|
|
|
|
|
|
|
Regional Lymph Node - Laterality |
|
|
|
|
Size of Metastasis in Lymph Nodes |
Extracapsular Extension of Regional Lymph Nodes |
Isolated Tumor Cells (ITCs) in Regional Lymph Node(s) |
Tumor Base Transection Status |
Tumor Infiltrating Lymphocytes (TIL) |
Growth Pattern of Primary Tumor |
Profound Immune Suppression |
|
|
|
| MiddleEar |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MouthOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MycosisFungoides |
Peripheral Blood Involvement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NasalCavity |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nasopharynx |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator |
| NETAmpulla |
|
|
|
Mitotic Count |
Serum Chromogranin A (CgA) Lab Value |
Urinary 5-HIAA Lab Value Level |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NETColon |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
Clinical Assessment of Regional Lymph Nodes |
|
|
|
|
|
|
|
|
Mitotic Count |
|
|
|
|
Serum Chromogranin A (CgA) Lab Value |
Urinary 5-HIAA Lab Value Level |
|
|
|
|
|
|
|
|
| NETRectum |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
Clinical Assessment of Regional Lymph Nodes |
|
|
|
|
|
|
|
|
Mitotic Count |
|
|
|
|
Serum Chromogranin A (CgA) Lab Value |
Urinary 5-HIAA Lab Value Level |
|
|
|
|
|
|
|
|
| NETSmallIntestine |
OBSOLETE (Pre-Operative Carcinoembryonic Antigen (CEA)) |
|
|
|
|
Mitotic Count |
|
|
|
|
Serum Chromogranin A (CgA) Lab Value |
Urinary 5-HIAA Lab Value Level |
|
|
|
|
|
|
|
|
|
|
|
|
|
| NETStomach |
Clinical Assessment of Regional Lymph Nodes |
|
|
|
|
Mitotic Count |
|
|
|
|
Serum Chromogranin A (CgA) Lab Value |
Urinary 5-HIAA Lab Value Level |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Orbit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Oropharynx |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ovary |
Carbohydrate Antigen 125 (CA-125) |
FIGO Stage |
Residual Tumor Status and Size After Primary Cytoreduction
Surgery |
Tumor Location after Primary Cytoreduction (Debulking) Surgery |
Malignant Ascites |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PalateHard |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PalateSoft |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PancreasBodyTail |
CA 19-9 Lab Value |
Serum Chromogranin A (CgA) Lab Value |
Mitotic Count |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PancreasHead |
CA 19-9 Lab Value |
Serum Chromogranin A (CgA) Lab Value |
Mitotic Count |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PancreasOther |
CA 19-9 Lab Value |
Serum Chromogranin A (CgA) Lab Value |
Mitotic Count |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ParotidGland |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Penis |
|
|
|
|
|
|
|
|
|
Involvement of Corpus Spongiosum/Corpus Cavernosum |
Poorly Differentiated Tumor Percentage |
HPV (Human Papilloma Virus) Status |
|
|
|
Size of Metastasis in Lymph Nodes |
Extranodal Extension of Regional Lymph Nodes |
|
|
|
|
|
|
|
|
| Peritoneum |
Grade for Sarcomas |
Neurovascular Invasion |
Bone invasion |
Pathologic P1: Source of pathologic metastatic specimen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator |
| PeritoneumFemaleGen |
Carbohydrate Antigen 125 (CA-125) |
FIGO Stage |
Residual Tumor Status and Size After Primary Cytoreduction
Surgery |
Tumor Location after Primary Cytoreduction (Debulking) Surgery |
Malignant Ascites |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator |
| PharyngealTonsil |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schema Discriminator |
| PharynxOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placenta |
Prognostic Scoring Index Table 1 |
FIGO Stage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pleura |
Pleural Effusion |
Histologic Subtype |
History of asbestos exposure |
Presence of chest pain |
PET Standardized Uptake Values (SUV) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prostate |
Prostatic Specific Antigen (PSA) Lab Value |
Prostatic Specific Antigen (PSA) Interpretation |
CS Extension - Pathologic Extension |
Prostate Apex Involvement (OBSOLETE: Prostatic Acid Phosphatase
(PAP)) |
OBSOLETE (Gleason's Primary Pattern and Secondary Pattern Value) |
OBSOLETE (Gleason's Score) |
Gleason's Primary Pattern and Secondary Pattern Value on Needle
Core Biopsy/TURP |
Gleason's Score on Needle Core Biopsy/TURP |
Gleason's Primary Pattern and Secondary Pattern Value on
Prostatectomy/Autopsy |
Gleason's Score on Prostatectomy/Autopsy |
Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy |
Number of Cores Positive |
Number of Cores Examined |
Needle Core Biopsy Findings |
Clinical Staging Procedures Performed |
|
|
|
|
|
|
|
|
|
|
| Rectum |
Carcinoembryonic Antigen (CEA) |
Clinical Assessment of Regional Lymph Nodes |
Carcinoembryonic Antigen (CEA) Lab Value |
Tumor Deposits |
Tumor Regression Grade |
Circumferential Resection Margin (CRM) |
Micro-satellite Instability |
Perineural Invasion |
KRAS |
18q Loss of Heterozygosity (LOH) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RespiratoryOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Retinoblastoma |
Extension Evaluated at Enucleation |
RB Gene Mutation |
Family History of Retinoblastoma |
Primary Globe-Sparing Treatment Failure |
Linear Choroidal Invasion |
Clinical Extension for Second Eye |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Retroperitoneum |
Grade for Sarcomas |
Neurovascular Invasion |
Bone invasion |
Pathologic P1: Source of pathologic metastatic specimen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SalivaryGlandOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Scrotum |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
Clark's Level |
Perineural Invasion |
High Risk Features |
|
|
|
Size of Lymph Nodes |
|
|
|
|
|
|
|
|
|
| SinusEthmoid |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SinusMaxillary |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SinusOther |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Skin |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
Clark's Level |
Perineural Invasion |
High Risk Features |
|
|
|
Size of Lymph Nodes |
|
|
|
|
|
|
|
|
|
| SkinEyelid |
Measured Thickness (Depth) for Squamous Cell Carcinoma |
Clark's Level |
Clinical Status of Lymph Nodes |
Size of Lymph Nodes |
Sentinel Lymph Node Biopsy |
Perineural Invasion |
Tumor Necrosis |
Pagetoid Spread |
Mohs Layers |
Prior Radiation |
HIV Status |
Solid Organ Transplant |
Leukemia |
Multiple Carcinomas |
Muir-Torre Syndrome |
Xeroderma Pigmentosa |
|
|
|
|
|
|
|
|
|
| SmallIntestine |
Carcinoembryonic Antigen (CEA) |
Clinical Assessment of Regional Lymph Nodes |
Carcinoembryonic Antigen (CEA) Lab Value |
Crohn Disease |
Micro-satellite Instability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SoftTissue |
Grade for Sarcomas |
Neurovascular Invasion |
Bone invasion |
Pathologic P1: Source of pathologic metastatic specimen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stomach |
Clinical Assessment of Regional Lymph Nodes |
Specific Location of Tumor |
|
|
|
|
|
|
|
|
|
|
Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Lab Value |
CA 19-9 Lab Value |
|
|
|
|
|
|
|
|
|
Involvement of Cardia and Distance from Esophagogastric Junction
(EGJ) |
| SubmandibularGland |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Testis |
OBSOLETE (Alpha Fetoprotein (AFP)) |
OBSOLETE (Human chorionic gonadotropin (hCG)) |
OBSOLETE (LDH) |
Radical Orchiectomy Performed |
Size of Metastasis in Lymph Nodes |
Preorchiectomy Alpha Fetoprotein (AFP) Lab Value |
Preorchiectomy Alpha Fetoprotein (AFP) Interpretation |
Preorchiectomy Human chorionic gonadotropin (hCG) Lab Value |
Preorchiectomy Human chorionic gonadotropin (hCG) Interpretation |
Preorchiectomy LDH Interpretation |
Persistence of Elevated Serum Tumor Markers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thyroid |
Solitary vs Multifocal Tumor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TongueAnterior |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
Measured Thickness (Depth) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TongueBase |
Size of Lymph Nodes |
OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck |
Levels I-III, Lymph Nodes for Head and Neck |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck |
Levels VI-VII and Facial Lymph Nodes for Head and Neck |
Parapharyngeal, Parotid, and Suboccipital/Retroauricular Lymph
Nodes, Lymph Nodes for Head and Neck |
Upper and Lower Cervical Node Levels |
Extracapsular Extension Clinically, Lymph Nodes for Head and Neck |
Extracapsular Extension Pathologically, Lymph Nodes for Head and
Neck |
HPV (Human Papilloma Virus) Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trachea |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Urethra |
WHO/ISUP Grade |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UrinaryOther |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vagina |
Figo Stage |
Pelvic Nodal Status |
Assessment Method of Pelvic Nodal Status |
Para-Aortic Nodal Status |
Assessment Method of Para-aortic Nodal Status |
Distant (mediastinal, scalene) Node Status |
Assessment Method of Distant (mediastinal, scalene) Node Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vulva |
|
|
|
|
|
|
|
|
|
FIGO Stage |
Regional Lymph Node - Laterality |
Pelvic Nodal Status |
Assessment Method of Pelvic Nodal Status |
Femoral Inguinal Nodal Status |
Assessment Method of Femoral Inguinal Nodal Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|